• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/20/23 11:02:17 AM ET
    $ARQQ
    $BAX
    $BKD
    $CRON
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ARQQ alert in real time by email

     

    Friday saw 23 companies set new 52-week lows.

    Significant Points From Today's 52-Week Lows:

    • L3Harris Technologies (NYSE:LHX) was the largest firm by market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was Digital Brands Group (NASDAQ:DBGI).
    • Windtree Therapeutics (NASDAQ:WINT) saw the most pronounced move, as shares traded down 26.62% to hit its new 52-week low.
    • Arqit Quantum (NASDAQ:ARQQ) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.

    Stocks that set new 52-week lows on Friday are as follows:

    • L3Harris Technologies (NYSE:LHX) stock set a new 52-week low of $190.11 on Friday, moving down 0.2%.
    • Hormel Foods (NYSE:HRL) stock hit $44.10 on Friday morning, setting a new 52-week low for a change of down 0.29%.
    • Baxter Intl (NYSE:BAX) stock hit a yearly low of $43.25. The stock was down 0.02% for the day.
    • Globant (NYSE:GLOB) stock dropped to a yearly low on Friday of $154.53. Shares traded down 0.11%.
    • National Fuel Gas (NYSE:NFG) stock dropped to a yearly low on Friday of $57.60. Shares traded down 0.95%.
    • Lumen Technologies (NYSE:LUMN) stock broke to a new 52-week low of $4.96 on Friday. Shares of the company traded up 1.62%.
    • Intellia Therapeutics (NASDAQ:NTLA) stock dropped to a yearly low on Friday of $32.44. Shares traded down 1.68%.
    • Granite Ridge Resources (NYSE:GRNT) stock broke to a new 52-week low of $7.83 on Friday. Shares of the company traded down 1.26%.
    • Cronos Group (NASDAQ:CRON) stock hit a new 52-week low of $2.39. The stock was down 0.62% on the session.
    • Skyward Specialty (NASDAQ:SKWD) stock hit $17.50 on Friday morning, setting a new 52-week low for a change of down 2.39%.
    • Brookdale Senior Living (NYSE:BKD) shares hit a yearly low of $2.37. The stock was up 1.86% on the session.
    • Domo (NASDAQ:DOMO) shares hit a yearly low of $11.35. The stock was down 9.87% on the session.
    • Arqit Quantum (NASDAQ:ARQQ) stock hit a yearly low of $2.02. The stock was 0.0% (flat) for the day.
    • KNOT Offshore Partners (NYSE:KNOP) stock broke to a new 52-week low of $5.54 on Friday. Shares of the company traded down 2.62%.
    • Rite Aid (NYSE:RAD) stock broke to a new 52-week low of $3.17 on Friday. Shares of the company traded up 1.88%.
    • FaZe Holdings (NASDAQ:FAZE) shares were down 7.96% for the day, having made a 52-week low of $0.92.
    • Lipella Pharmaceuticals (NASDAQ:LIPO) stock broke to a new 52-week low of $2.59 on Friday. Shares of the company traded up 1.51%.
    • Tricida (NASDAQ:TCDA) shares set a new 52-week low of $0.12. The stock traded down 3.82%.
    • Windtree Therapeutics (NASDAQ:WINT) shares were down 26.62% for the day, having made a 52-week low of $0.14.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ARQQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARQQ
    $BAX
    $BKD
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Domo Inc.
    $DOMO
    2/13/2026$3.50Mkt Outperform → Mkt Underperform
    Citizens
    Lumen Technologies Inc.
    $LUMN
    2/4/2026Outperform → Mkt Perform
    Raymond James
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Globant S.A.
    $GLOB
    1/6/2026$72.00Hold
    Truist
    Brookdale Senior Living Inc.
    $BKD
    1/6/2026$13.00Underperform → Buy
    BofA Securities
    L3Harris Technologies Inc.
    $LHX
    12/16/2025$367.00Equal-Weight → Overweight
    Morgan Stanley
    L3Harris Technologies Inc.
    $LHX
    12/12/2025$331.00Buy
    Citigroup
    KNOT Offshore Partners LP
    $KNOP
    12/8/2025Buy → Neutral
    Alliance Global Partners
    More analyst ratings

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Linear Diankha sold $355,050 worth of shares (45,000 units at $7.89), decreasing direct ownership by 19% to 198,229 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/20/26 7:09:04 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Director Mcdonnell Michael R. was granted 1,811 shares (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    2/18/26 4:06:26 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    New insider Mcdonnell Michael R. claimed no ownership of stock in the company (SEC Form 3)

    3 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    2/18/26 4:04:14 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Director Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    1/7/26 4:05:06 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Chase William J bought $1,003,000 worth of shares (100,000 units at $10.03), increasing direct ownership by 288% to 134,693 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    8/22/25 4:30:14 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    62% of respondents cite data sovereignty and privacy risks as the biggest factor slowing AI projects in the public cloud

    LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Data sovereignty is fast becoming make or break for AI-driven network safety projects. Yet new survey data shows that one in six organisations cannot rely on access to facilities with guaranteed data sovereignty, while data sovereignty and privacy risks are cited as the leading factor slowing AI projects in the public cloud. These are the findings of research sponsored by Arqit (NASDAQ:ARQQ, ARQQW)) and Intel that are set to be unveiled at MWC Barcelona 2026. As operators and enterprises push AI deeper into network operations, security teams are being asked to both move faster against escalating threats and ensure sensitive data remains under sove

    2/26/26 9:00:00 AM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    NYSE Content Update: 'Patty' at Center of Burger King's New BK Assistant AI Solution

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 26, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Laura Diorio delivers the pre-market update on February 26thStocks are little changed early Thursday after Nvidia reported earnings after the close on Wednesday, beating estimates on the top and bottom lines.Burker King has unveiled its AI-powered BK assistant solution, which aims to deliver real-time, voice-enabled intelligence to restaurant teams.Lumen Technologies (NYSE:LUM

    2/26/26 8:55:00 AM ET
    $AER
    $ICE
    $LUMN
    Diversified Commercial Services
    Consumer Discretionary
    Investment Bankers/Brokers/Service
    Finance

    Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

    HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027Process underway to reactivate global sites for MAGNITUDE-2 Phase 3 clinical trial of nex-z in ATTRv-PN; enrollment completion expected in second half of 2026FDA engagement ongoing to resolve clinical hold on MAGNITUDE Phase 3 clinical trial of nex-z in ATTR-CM Ended 2025 with approximately $605 million in cash, cash equivalents and marketable securities; expected to fund operations into the second half of 2027 CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading biopharmaceutical com

    2/26/26 7:30:00 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Domo downgraded by Citizens with a new price target

    Citizens downgraded Domo from Mkt Outperform to Mkt Underperform and set a new price target of $3.50

    2/13/26 8:28:18 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Lumen Technologies downgraded by Raymond James

    Raymond James downgraded Lumen Technologies from Outperform to Mkt Perform

    2/4/26 8:28:23 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    SEC Filings

    View All

    SEC Form 10-Q filed by Hormel Foods Corporation

    10-Q - HORMEL FOODS CORP /DE/ (0000048465) (Filer)

    2/26/26 1:43:32 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Intellia Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)

    2/26/26 7:45:25 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 10-K filed by Cronos Group Inc.

    10-K - Cronos Group Inc. (0001656472) (Filer)

    2/26/26 7:38:28 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Financials

    Live finance-specific insights

    View All

    Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

    HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027Process underway to reactivate global sites for MAGNITUDE-2 Phase 3 clinical trial of nex-z in ATTRv-PN; enrollment completion expected in second half of 2026FDA engagement ongoing to resolve clinical hold on MAGNITUDE Phase 3 clinical trial of nex-z in ATTR-CM Ended 2025 with approximately $605 million in cash, cash equivalents and marketable securities; expected to fund operations into the second half of 2027 CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading biopharmaceutical com

    2/26/26 7:30:00 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    HORMEL FOODS REPORTS FIRST QUARTER FISCAL 2026 RESULTS

    Company Achieves Net Sales of $3 billion and Organic Net Sales1 Growth of 2%Company Reports Diluted EPS of $0.33; Adjusted Diluted EPS1 of $0.34Updates GAAP Guidance; Reiterates Adjusted Full Year Fiscal 2026 GuidanceAUSTIN, Minn., Feb. 26, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today reported results for the first quarter of fiscal 2026, which ended January 25, 2026. All comparisons are to the comparable period of fiscal 2025, unless otherwise noted. EXECUTIVE SUMMARY — FIRST QUARTERNet sales of $3.03 billion; organi

    2/26/26 6:30:00 AM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

    CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will host a conference call on February 26, 2026, at 8 a.m. ET to discuss its fourth quarter and full-year 2025 financial results and business updates. To join a webcast of the call, please visit this link. To join the teleconference, U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference c

    2/19/26 7:30:00 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Hormel Foods Appoints Donald Monk as Company's First Chief Technology Officer

    New role underscores company's commitment to modernizing technology, digital and data capabilitiesAUSTIN, Minn., Feb. 24, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Donald Monk as chief technology officer, effective March 23. In this newly created role, Monk will serve as the company's senior-most technology leader, responsible for envisioning, aligning and delivering the enterprise technology, digital and data strategy that supports long‑term growth. "Don is an exceptional technology le

    2/24/26 4:30:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Hormel Foods Names Will Bonifant Group Vice President and Chief Supply Chain Officer

    Seasoned supply chain leader to oversee global procurement, manufacturing, planning, logistics and engineering AUSTIN, Minn., Feb. 12, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Will Bonifant as group vice president and chief supply chain officer, effective March 9. In this role, Bonifant will lead the company's global supply chain, including procurement, manufacturing, planning, logistics, engineering and supply chain innovation. "Will is a proven supply chain leader who has scaled co

    2/12/26 5:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Lumen Technologies Appoints Jeff Sharritts as Chief Revenue Officer

    Veteran leader to deepen customer relationships, sharpen execution, and scale company's commercial engine in Lumen's next phase of transformation Lumen Technologies (NYSE: LUMN) today announced that Jeff Sharritts has been appointed Executive Vice President and Chief Revenue Officer, effective Feb. 4, 2026. He will report to Lumen CEO Kate Johnson and will lead Lumen's commercial strategy, including the Acceleration and Growth Team, with a focus on deepening customer relationships and driving profitable growth for the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203640994/en/LUMN) as EVP and Chief Revenue Officer

    2/3/26 4:01:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $ARQQ
    $BAX
    $BKD
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Windtree Therapeutics Inc.

    SC 13G/A - WINDTREE THERAPEUTICS INC /DE/ (0000946486) (Subject)

    11/14/24 7:15:44 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care